Together, these data support a model in which PDA selectively amplifies integrin-initiated signaling that propagates through the FAK–JNK axis, rather than reflecting nonspecific inhibitory effects of the compounds. This evidence concerns the gene PTK2 and Patent ductus arteriosus.